RYVU Therapeutics S.A. — AGM Information 2022

Aug 19, 2022

The Management Board of RyvuTherapeutics S.A. with its registered office in Kraków (_quot;theCompany_quot;), entered in the register of entrepreneurs of the NationalCourt Register kept by the District Court for Kraków-Śródmieście inKraków, XI Economic Division of the National Court Register under KRSnumber: 0000367359, acting pursuant to art. 399 § 1, art. 4021and art. 4022of the Commercial Companies Code, herebyconvenes the Extraordinary General Meeting of the Company for September19, 2022, at 10:00 o'clock,_#160;tobe held in Kraków at Leona Henryka Sternbach 2 Street, 30-394 Kraków (_quot;GeneralMeeting_quot;).

Agenda:

1._#160;_#160;_#160;_#160;_#160;-_#160;Opening of themeeting.

2._#160;_#160;_#160;_#160;_#160;_#160;-Election of theChairman of the Meeting.

3._#160;_#160;_#160;_#160;_#160;_#160;-Confirmation bythe Chairman that the Meeting has been duly convened andhas thecapacity to adopt resolutions.

4._#160;_#160;_#160;_#160;_#160;_#160;-Adoption of aresolution on waiving the election of the Scrutiny Committee.

5._#160;_#160;_#160;_#160;_#160;_#160;-Adoption of theagenda.

6._#160;_#160;_#160;_#160;_#160;_#160;-Adoption of aresolution on authorising the Company's Management Board to increase theCompany's share capital within the authorised capital, on the exclusionby the Management Board of the pre-emptive rights to shares issuedwithin the authorised capital in total or in part with the consent ofthe Supervisory Board and on amending the Company's Articles ofAssociation.

7._#160;_#160;_#160;_#160;_#160;_#160;-Adoption of aresolution on increasing the share capital of the Company by issuingshares, excluding the pre-emptive rights of the existing shareholders intotal, applying for the admission and introduction to trading on theregulated market of shares and rights to these shares (PDA), andamending the Company's Articles of Association.

8._#160;_#160;_#160;_#160;_#160;_#160;-Closing of themeeting.

The Management Board of theCompany is seeking authorisation from the General Meeting to issueshares within the limits of authorised capital until the end of 2024.This would enable implementation of the _quot;Ryvu Development Plans2022-2024_quot;. Only in the event that the authorised capital is notenacted, the Management Board has proposed to adopt a classic shareissue resolution. It is the intention of the Management Board to proposeto the General Meeting to withdraw from voting on the resolution on theissue of shares in the event of adoption of the authorised capital.

For complete information, pleasealso visit the Company's website at:https://ryvu.com/pl/inwestorzy-media/walne-zgromadzenia/